All Companies
Ticker IOVA
Foundation Sweep — share basis uncertain
You reached the page — here's exactly what IOVA is, and why it's out of scope for now.
What this ticker is
IOVA
Iovance Biotherapeutics Inc.
NASDAQ
Healthcare
Biotechnology
United States
Mkt cap $3.9B
Iovance Biotherapeutics Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing tumor infiltrating lymphocyte, or TIL, cell therapies for cancer. Its current portfolio centers on Amtagvi, an individualized cell therapy used in advanced melanoma, and Proleukin, which supports the treatment regimen. The company also adva…
Why we can't analyze it yet
F6 · Divisor contradicted by 2 independent witnesses · divisor 357,345 — 0 witness(es) agree [none]; CONFLICT with [eps_identity, dei]
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
share_basis_unverified